How Old Are You, Really? The New Science of Slowing Aging
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Free Clinical AI Briefs: https://www.healthit.com/signup?utm_source=podcast&utm_medium=audio&utm_campaign=pod_ep11 · Course: https://oncologyaiacademy.com/course?utm_source=podcast&utm_medium=audio&utm_campaign=pod_ep11
Two people can share a birthday and age very differently. Scientists call that difference biological age, and for the first time we can measure it, see what drives it inside our cells, and begin to change it.
In Episode 11, oncologist Jivesh Sharma, M.D., and Talia, our AI cohost, take a tour of the science: a map of what ages our cells (mTOR, AMPK, telomeres, senescent cells, DNA tags, mitochondria and inflammation), the clocks that now read organ age from a blood sample, the large GLP-1 trials showing protection for the heart, kidneys and liver, five strategies to watch (GLP-1 medicines, metformin, rapamycin, senolytics and cell reprogramming), and how AI is shortening every cycle of discovery.
Research cutoff: November 10, 2026. The predictions near the end are the host's own views, not established facts. The medicines discussed are prescription medicines with real side effects; decisions about them belong with you and your doctor.
Thank you for listening. Follow HealthIT.com for the next conversation. What should we explore next? Suggestions: https://www.healthit.com/feedback
Disclosure: This episode uses an authorized AI-generated version of Jivesh Sharma's voice and an AI cohost. Diagrams, scenarios and animations are labeled illustrations or study summaries, not patient data. Company-reported results are labeled as such. General education, not personal medical advice.
CHAPTERS
0:00 Same birthday, different bodies
0:46 Two kinds of age
1:31 A map of aging: what goes wrong inside our cells
3:22 Reading the clock: measuring biological age
4:30 Why measuring changes everything
4:59 The GLP-1 story: heart, kidneys, liver, brain
6:49 Five strategies to watch
8:53 How AI speeds it up
10:09 A checkup ten years from now
11:01 What to do today
11:41 Predictions
12:26 Thank you
KEY SOURCES (full list on the YouTube episode page)
López-Otín et al., Cell 2013 and 2023: hallmarks of aging
https://doi.org/10.1016/j.cell.2022.11.001
Oh et al., Nature 2023 and Nature Medicine 2025: organ ages from blood proteins
https://doi.org/10.1038/s41586-023-06802-1
Lincoff et al., NEJM 2023: semaglutide and cardiovascular outcomes (SELECT)
https://doi.org/10.1056/NEJMoa2307563
Perkovic et al., NEJM 2024: kidney outcomes (FLOW)
https://doi.org/10.1056/NEJMoa2403347
Sanyal et al., NEJM 2025: liver (ESSENCE)
https://doi.org/10.1056/NEJMoa2413258
Adamou et al., International Journal of Stroke 2024: stroke, eleven trials
https://doi.org/10.1177/17474930241253988
Cummings et al., Lancet 2026: semaglutide in early Alzheimer's disease
https://doi.org/10.1016/S0140-6736(26)00459-9
Bhatt, Pandey and Misra, Mechanisms of Ageing and Development 2026: metformin and telomeres
https://doi.org/10.1016/j.mad.2026.112241
Avsec et al., Nature 2026: AlphaGenome
https://doi.org/10.1038/s41586-025-10014-0
Loyal: LOY-002 FDA safety section accepted (company-reported)
https://loyal.com/posts/loy-002-tas-announcement